PetMed Express, Inc. Announces Delay in Fourth Quarter and Fiscal Year End Earnings Release and Conference Call

Rhea-AI Summary

PetMed Express (NASDAQ: PETS), operating as PetMeds and parent company of PetCareRx, has announced a delay in releasing its Q4 and fiscal year 2025 financial results. The earnings release and conference call, originally scheduled for June 10, 2025, have been postponed due to the need for additional time to complete the year-end audit process. The company expects to issue the earnings release, conduct the conference call, and file its Annual Report on Form 10-K by June 16, 2025.

Positive

• None.

Negative

• Delay in completing year-end audit process indicates potential accounting complexities or issues
• Postponement of earnings release and Form 10-K filing could raise investor concerns about financial reporting

News Market Reaction

-11.22%

1 alert

-11.22% News Effect

On the day this news was published, PETS declined 11.22%, reflecting a significant negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

DELRAY BEACH, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced it is delaying the release of the Company’s fourth quarter and fiscal year 2025 earnings release and subsequent conference call, which had been scheduled for June 10, 2025, because the Company requires additional time to complete the year-end audit process.

The Company anticipates that it will issue the earnings release, hold the related conference call, and file its Annual Report on Form 10-K as soon as possible, but no later than June 16, 2025.

About PetMed Express, Inc.

Founded in 1996, PetMeds is a leader in pioneering the digital pet pharmacy industry. As a national online retailer, PetMeds.com and PetCareRx.com are top choices for delivering preventive and chronic symptom prescriptions and OTC medications and products through their thousands of veterinary partners and a loyal customer base. Leveraging telehealth and insurance partnerships, they offer value and convenience to pet families at every stage of their pets' lives, whether dogs, cats, or horses. PetMeds and PetCareRx provide a comprehensive range of medications, food products, and essential supplies through their websites, www.PetMeds.com and www.PetCareRx.com.

Investor Contact:

ICR, LLC
John Mills
(646) 277-1254
Reed Anderson
(646) 277-1260
investor@petmeds.com

FAQ

Why did PetMed Express (PETS) delay its Q4 and FY2025 earnings release?

PetMed Express delayed the release because the company requires additional time to complete the year-end audit process.

When will PetMed Express (PETS) release its delayed Q4 and FY2025 earnings?

The company expects to release earnings, hold the conference call, and file Form 10-K no later than June 16, 2025.

What was the original date for PetMed Express (PETS) earnings release?

The earnings release and conference call were originally scheduled for June 10, 2025.

What regulatory filing is affected by PetMed Express (PETS) earnings delay?

The delay affects the filing of the company's Annual Report on Form 10-K.